Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 1780

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 12
Chunk 1780
---
 $0.6 million of stock-based compensation expense in 2023. Refer to discussion below for further detail. Also included in
    general and administrative expense is the stock-based compensation expense for the options awards to non-employee directors as discussed
    above.

    F-31

10.
Warrants

As
of December 31, 2024 and 2023, the following warrants to purchase common stock were outstanding:

 Schedule of Warrants

    December 31, 2024

    Issuance Date 
    Number of Shares Issuable  
    Exercise Price  
    Classification  
    Expiration
  
    Lender/Name 

    Second Street Capital (1) (2) 
    February 2023 
     426,427  
    $8.06  
     (2) 
    3/8/2026
  
    Second Street Capital (1) 
    February 2023 
     85,285  
    $8.06  
     Equity-classified  
    4/22/2026
  
    Second Street Capital (1) 
    February 2023 
     102,342  
    $7.47  
     Equity-classified  
    9/30/2026
  
    Second Street Capital 
    February 2023 
     75,000  
    $10.34  
     Equity-classified  
    2/15/2028
  
    Second Street Capital 
    March 2023 
     200,000  
    $10.34  
     Equity-classified  
    3/29/2028
  
    Second Street Capital 
    March 2023 
     150,000  
    $11.50  
     Equity-classified  
    3/31/2028
  
    McKra Investments warrant 
    March 2023 
     200,000  
    $10.34  
     Equity-classified  
    3/28/2028
  
    Special Forces F9 warrant 
    March 2023 
     150,000  
    $11.50  
     Equity-classified  
    3/7/2028
  
    Public Warrants 
    -(4) 
     5,250,000  
    $11.50